Fly News Breaks for February 26, 2015
BMRN
Feb 26, 2015 | 08:19 EDT
Cowen raised its price target on BioMarin to $125 from $115 following its Q4 report, citing company guidance and its pipeline potential. Cowen considers BioMarin a core biotech holding and reiterated its Outperform rating on the stock.
News For BMRN From the Last 2 Days
There are no results for your query BMRN